A comparative study of ambulatory central hemodynamics and arterial stiffness parameters in peritoneal dialysis and hemodialysis patients.


Journal

Journal of hypertension
ISSN: 1473-5598
Titre abrégé: J Hypertens
Pays: Netherlands
ID NLM: 8306882

Informations de publication

Date de publication:
12 2020
Historique:
pubmed: 23 7 2020
medline: 22 6 2021
entrez: 23 7 2020
Statut: ppublish

Résumé

Ambulatory pulse-wave velocity (PWV), augmentation pressure, and augmentation index (AIx) are associated with increased cardiovascular events and death in hemodialysis. The intermittent nature of hemodialysis generates a distinct ambulatory pattern, with a progressive increase of augmentation pressure and AIx during the interdialytic interval. No study so far has compared the ambulatory course of central hemodynamics and PWV between peritoneal dialysis and hemodialysis patients. Thirty-eight patients under peritoneal dialysis and 76 patients under hemodialysis matched in a 1 : 2 ratio for age, sex and dialysis vintage underwent 48-h ambulatory blood pressure (BP) monitoring with the oscillometric Mobil-O-Graph device. Parameters of central hemodynamics [central SBP, DBP and pulse pressure (PP)], wave reflection [AIx, heart rate-adjusted AIx; AIx(75) and augmentation pressure] and PWV were estimated from the 48-h recordings. Over the total 48-h period, no significant differences were observed between peritoneal dialysis and hemodialysis patients in mean levels of central SBP, DBP, PP, augmentation pressure, AIx, AIx(75) and PWV. However, patients under peritoneal dialysis and hemodialysis displayed different trajectories in all the above parameters over the course of the recording: in peritoneal dialysis patients no differences were noted in central SBP (125.0 ± 19.2 vs. 126.0 ± 17.8 mmHg, P = 0.25), DBP, PP, augmentation pressure (13.0 ± 6.8 vs. 13.7 ± 7. mmHg, P = 0.15), AIx(75) (25.9 ± 6.9 vs. 26.3 ± 7.8%, P = 0.54) and PWV (9.5 ± 2.1 vs. 9.6 ± 2.1 m/s, P = 0.27) from the first to the second 24-h period of the recording. In contrast, hemodialysis patients showed significant increases in all these parameters from the first to second 24 h (SBP: 119.5 ± 14.4 vs. 124.6 ± 15.0 mmHg, P < 0.001; augmentation pressure: 10.9 ± 5.3 vs. 13.1 ± 6.3 mmHg, P < 0.001; AIx(75): 24.7 ± 7.6 vs. 27.4 ± 7.9%, P < 0.001; PWV: 9.1 ± 1.8 vs. 9.3 ± 1.8 m/s, P < 0.001). Peritoneal dialysis patients had numerically higher levels than hemodialysis patients in all the above parameters during all periods studied and especially during the first 24-h. Central BP, wave reflection indices and PWV during a 48-h recording are steady in peritoneal dialysis but gradually increase in hemodialysis patients. During all studied periods, peritoneal dialysis patients have numerically higher levels of all studied parameters, a fact that could relate to higher cardiovascular risk.

Sections du résumé

BACKGROUND
Ambulatory pulse-wave velocity (PWV), augmentation pressure, and augmentation index (AIx) are associated with increased cardiovascular events and death in hemodialysis. The intermittent nature of hemodialysis generates a distinct ambulatory pattern, with a progressive increase of augmentation pressure and AIx during the interdialytic interval. No study so far has compared the ambulatory course of central hemodynamics and PWV between peritoneal dialysis and hemodialysis patients.
METHODS
Thirty-eight patients under peritoneal dialysis and 76 patients under hemodialysis matched in a 1 : 2 ratio for age, sex and dialysis vintage underwent 48-h ambulatory blood pressure (BP) monitoring with the oscillometric Mobil-O-Graph device. Parameters of central hemodynamics [central SBP, DBP and pulse pressure (PP)], wave reflection [AIx, heart rate-adjusted AIx; AIx(75) and augmentation pressure] and PWV were estimated from the 48-h recordings.
RESULTS
Over the total 48-h period, no significant differences were observed between peritoneal dialysis and hemodialysis patients in mean levels of central SBP, DBP, PP, augmentation pressure, AIx, AIx(75) and PWV. However, patients under peritoneal dialysis and hemodialysis displayed different trajectories in all the above parameters over the course of the recording: in peritoneal dialysis patients no differences were noted in central SBP (125.0 ± 19.2 vs. 126.0 ± 17.8 mmHg, P = 0.25), DBP, PP, augmentation pressure (13.0 ± 6.8 vs. 13.7 ± 7. mmHg, P = 0.15), AIx(75) (25.9 ± 6.9 vs. 26.3 ± 7.8%, P = 0.54) and PWV (9.5 ± 2.1 vs. 9.6 ± 2.1 m/s, P = 0.27) from the first to the second 24-h period of the recording. In contrast, hemodialysis patients showed significant increases in all these parameters from the first to second 24 h (SBP: 119.5 ± 14.4 vs. 124.6 ± 15.0 mmHg, P < 0.001; augmentation pressure: 10.9 ± 5.3 vs. 13.1 ± 6.3 mmHg, P < 0.001; AIx(75): 24.7 ± 7.6 vs. 27.4 ± 7.9%, P < 0.001; PWV: 9.1 ± 1.8 vs. 9.3 ± 1.8 m/s, P < 0.001). Peritoneal dialysis patients had numerically higher levels than hemodialysis patients in all the above parameters during all periods studied and especially during the first 24-h.
CONCLUSION
Central BP, wave reflection indices and PWV during a 48-h recording are steady in peritoneal dialysis but gradually increase in hemodialysis patients. During all studied periods, peritoneal dialysis patients have numerically higher levels of all studied parameters, a fact that could relate to higher cardiovascular risk.

Identifiants

pubmed: 32694339
doi: 10.1097/HJH.0000000000002574
pii: 00004872-202012000-00011
doi:

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2393-2403

Références

Saran R, Robinson B, Abbott KC, Agodoa LYC, Bragg-Gresham J, Balkrishnan R, et al. US Renal Data System 2018 Annual Data Report: epidemiology of kidney disease in the United States. Am J Kidney Dis 2019; 73:A7–A8.
Wanner C, Amann K, Shoji T. The heart and vascular system in dialysis. Lancet 2016; 388:276–284.
Zoccali C. Cardiovascular risk in uraemic patients-is it fully explained by classical risk factors? Nephrol Dial Transplant 2000; 15:454–457.
Georgianos PI, Sarafidis PA, Liakopoulos V. Arterial stiffness: a novel risk factor for kidney injury progression? Am J Hypertens 2015; 28:958–965.
Briet M, Boutouyrie P, Laurent S, London GM. Arterial stiffness and pulse pressure in CKD and ESRD. Kidney Int 2012; 82:388–400.
Georgianos PI, Sarafidis PA, Lasaridis AN. Arterial stiffness: a novel cardiovascular risk factor in kidney disease patients. Curr Vasc Pharmacol 2015; 13:229–238.
London GM, Blacher J, Pannier B, Guerin AP, Marchais SJ, Safar ME. Arterial wave reflections and survival in end-stage renal failure. Hypertension 2001; 38:434–438.
Laurent S, Cockcroft J, Van Bortel L, Boutouyrie P, Giannattasio C, Hayoz D, et al. European Network for Non-invasive Investigation of Large ArteriesExpert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 2006; 27:2588–2605.
Safar ME, Blacher J, Pannier B, Guerin AP, Marchais SJ, Guyonvarc’h PM, London GM. Central pulse pressure and mortality in end-stage renal disease. Hypertension 2002; 39:735–738.
Xu T, Xie J, Zong X, Wang W, Ren H, Chen N. Pulse wave velocity: a valuable predictor for cardio-cerebrovascular disease and death in PD patients. Blood Purif 2015; 40:203–208.
Fortier C, Mac-Way F, Desmeules S, Marquis K, De Serres SA, Lebel M, et al. Aortic-brachial stiffness mismatch and mortality in dialysis population. Hypertension 2015; 65:378–384.
Sarafidis PA, Loutradis C, Karpetas A, Tzanis G, Piperidou A, Koutroumpas G, et al. Ambulatory pulse wave velocity is a stronger predictor of cardiovascular events and all-cause mortality than office and ambulatory blood pressure in hemodialysis patients. Hypertension 2017; 70:148–157.
Georgianos PI, Sarafidis PA, Malindretos P, Nikolaidis P, Lasaridis AN. Hemodialysis reduces augmentation index but not aortic or brachial pulse wave velocity in dialysis-requiring patients. Am J Nephrol 2011; 34:407–414.
Georgianos PI, Sarafidis PA, Haidich AB, Karpetas A, Stamatiadis D, Nikolaidis P, et al. Diverse effects of interdialytic intervals on central wave augmentation in haemodialysis patients. Nephrol Dial Transplant 2013; 28:2160–2169.
Karpetas A, Sarafidis PA, Georgianos PI, Protogerou A, Vakianis P, Koutroumpas G, et al. Ambulatory recording of wave reflections and arterial stiffness during intra- and interdialytic periods in patients treated with dialysis. Clin J Am Soc Nephrol 2015; 10:630–638.
Koutroumbas G, Georgianos PI, Sarafidis PA, Protogerou A, Karpetas A, Vakianis P, et al. Ambulatory aortic blood pressure, wave reflections and pulse wave velocity are elevated during the third in comparison to the second interdialytic day of the long interval in chronic haemodialysis patients. Nephrol Dial Transplant 2015; 30:2046–2053.
Georgianos PI, Sarafidis PA. Pro: should we move to more frequent haemodialysis schedules? Nephrol Dial Transpantl 2015; 30:18–22.
Georgianos PI, Sarafidis PA, Sinha AD, Agarwal R. Adverse effects of conventional thrice-weekly hemodialysis: is it time to avoid 3-day interdialytic intervals? Am J Nephrol 2015; 41:400–408.
Sarafidis P, Faitatzidou D, Papagianni A. Benefits and risks of frequent or longer haemodialysis: weighing the evidence. Nephrol Dial Transplant 2020; gfaa023.
Stürmer T, Brenner H. Degree of matching and gain in power and efficiency in case-control studies. Epidemiology 2001; 12:101–108.
Parati G, Stergiou G, O’Brien E, Asmar R, Beilin L, Bilo G, et al. European Society of Hypertension practice guidelines for ambulatory blood pressure monitoring. J Hypertens 2014; 32:1359–1366.
Franssen PM, Imholz BP. Evaluation of the Mobil-O-Graph new generation ABPM device using the ESH criteria. Blood Press Monit 2010; 15:229–231.
Weber T, Wassertheurer S, Rammer M, Maurer E, Hametner B, Mayer CC, et al. Validation of a brachial cuff-based method for estimating central systolic blood pressure. Hypertension 2011; 58:825–832.
Weber T, Wassertheurer S, Hametner B, Parragh S, Eber B. Noninvasive methods to assess pulse wave velocity: comparison with the invasive gold standard and relationship with organ damage. J Hypertens 2015; 33:1023–1031.
Sarafidis PA, Georgianos PI, Karpetas A, Bikos A, Korelidou L, Tersi M, et al. Evaluation of a novel brachial cuff-based oscillometric method for estimating central systolic pressure in hemodialysis patients. Am J Nephrol 2014; 40:242–250.
Covic A, Goldsmith DJ, Florea L, Gusbeth-Tatomir P, Covic M. The influence of dialytic modality on arterial stiffness, pulse wave reflections, and vasomotor function. Perit Dial Int 2004; 24:365–372.
Chang JH, Yoon SJ, Han SH, Shin SK, Jeon DW, Yang JY, et al. The impact of dialysis modality on arterial stiffness in patients with end-stage renal disease. Ren Fail 2010; 32:947–953.
Chung A, Yang H, Kim JM, Sigrist MK, Brin G, Chum E, et al. Arterial stiffness and functional properties in chronic kidney disease patients on different dialysis modalities: an exploratory study. Nephrol Dial Transplant 2010; 25:4031–4041.
Mimura T, Takenaka T, Kanno Y, Aoki H, Ohshima J, Suzuki H. Comparison of changes in pulse wave velocity in patients on continuous ambulatory peritoneal dialysis and hemodialysis one year after introduction of dialysis therapy. Adv Perit Dial 2005; 21:139–145.
Mac-Way F, Couture V, Utescu MS, Ignace S, De Serres SA, Loignon RC, et al. Advanced glycation end products, aortic stiffness, and wave reflection in peritoneal dialysis as compared to hemodialysis. Int Urol Nephrol 2014; 46:817–824.
Stróżecki P, Donderski R, Kardymowicz A, Manitius J. Comparison of arterial stiffness in end-stage renal disease patients treated with peritoneal dialysis or hemodialysis. Pol Arch Med Wewn 2012; 122:33–39.
Yang L, Lin Y, Ye C, Mao Z, Rong S, Zhao X, et al. Effects of peritoneal dialysis and hemodialysis on arterial stiffness compared with predialysis patients. Clin Nephrol 2011; 75:188–194.
Roehm B, Gulati G, Weiner DE. Heart failure management in dialysis patients: many treatment options with no clear evidence. Semin Dial 2020; 33:198–208.
Alexandrou ME, Loutradis C, Schoina M, Tzanis G, Dimitriadis C, Sachpekidis V, et al. Ambulatory blood pressure profile and blood pressure variability in peritoneal dialysis compared with hemodialysis and chronic kidney disease patients. Hypertens Res 2020; doi:10.1038/s41440-020-0442-0 [Epub ahead of print].
doi: 10.1038/s41440-020-0442-0
Kim Y, Biesen WV. Fluid overload in peritoneal dialysis patients. Semin Nephrol 2017; 37:43–53.
Alexandrou ME, Balafa O, Sarafidis PA. Assessment of hydration status in peritoneal dialysis patients: validity, prognostic value, strengths and limitations of available techniques. Am J Nephrol 2020; [Epub ahead of print].
Kocyigit I, Sipahioglu MH, Orscelik O, Unal A, Celik A, Abbas SR, et al. The association between arterial stiffness and fluid status in peritoneal dialysis patients. Perit Dial Int 2014; 34:781–790.
Kocyigit I, Gungor O, Unal A, Orscelik O, Eroglu E, Tunca O, et al. The effect of strict volume control on cardiac biomarker and arterial stiffness in peritoneal dialysis patients. Clin Nephrol 2014; 81:238–246.
Yang JH, Cheng LT, Gu Y, Tang LJ, Wang T, Lindholm MB, et al. Volume overload in patients treated with continuous ambulatory peritoneal dialysis associated with reduced circadian blood pressure variation. Blood Purif 2008; 26:399–403.
Sarafidis PA, Loutradis C, Mayer CC, Karpetas A, Pagkopoulou E, Bikos A, et al. Weak within-individual association of blood pressure and pulse wave velocity in hemodialysis is related to adverse outcomes. J Hypertens 2019; 37:2200–2208.
Vonesh EF, Snyder JJ, Foley RN, Collins AJ. Mortality studies comparing peritoneal dialysis and hemodialysis: what do they tell us? Kidney Int Suppl 2006; 70:S3-SL 11.
Maruyama Y, Higuchi C, Io H, Wakabayashi K, Tsujimoto H, Tsujimoto Y, et al. Comparison of peritoneal dialysis and hemodialysis as first renal replacement therapy in patients with end-stage renal disease and diabetes: a systematic review. Ren Replace Ther 2019; 5:44.
Johnson DW, Dent H, Hawley CM, McDonald SP, Rosman JB, Brown FG, et al. Association of dialysis modality and cardiovascular mortality in incident dialysis patients. Clin J Am Soc Nephrol 2009; 4:1620–1628.
Wang IK, Lin CL, Yen TH, Lin SY, Sung FC. Comparison of survival between hemodialysis and peritoneal dialysis patients with end-stage renal disease in the era of icodextrin treatment. Eur J Intern Med 2018; 50:69–74.
Wong B, Ravani P, Oliver MJ, Holroyd-Leduc J, Venturato L, Garg AX, et al. Comparison of patient survival between hemodialysis and peritoneal dialysis among patients eligible for both modalities. Am J Kidney Dis 2018; 71:344–351.
Sarafidis PA, Persu A, Agarwal R, Burnier M, de Leeuw P, Ferro C, et al. Hypertension in dialysis patients: a consensus document by the European Renal and Cardiovascular Medicine (EURECA-m) working group of the European Renal Association - European Dialysis and Transplant Association (ERA-EDTA) and the Hypertension and the Kidney working group of the European Society of Hypertension (ESH). J Hypertens 2017; 35:657–676.
Bello AK, Johnson DW, Feehally J, Harris D, Jindal K, Lunney M, et al. Global Kidney Health Atlas (GKHA): design and methods. Kidney Int Suppl (2011) 2017; 7:145–153.

Auteurs

Maria-Eleni Alexandrou (ME)

Department of Nephrology, Hippokration Hospital, Aristotle University of Thessaloniki.
Department of Nephrology, Papageorgiou General Hospital, Thessaloniki.

Charalampos Loutradis (C)

Department of Nephrology, Hippokration Hospital, Aristotle University of Thessaloniki.

Olga Balafa (O)

Department of Nephrology, University Hospital of Ioannina, Ioannina.

Marieta Theodorakopoulou (M)

Department of Nephrology, Hippokration Hospital, Aristotle University of Thessaloniki.

George Tzanis (G)

Department of Nephrology, Hippokration Hospital, Aristotle University of Thessaloniki.

Dimitra Bakaloudi (D)

Department of Nephrology, Hippokration Hospital, Aristotle University of Thessaloniki.

Chrysostomos Dimitriadis (C)

Department of Nephrology, Hippokration Hospital, Aristotle University of Thessaloniki.

Panagiotis Pateinakis (P)

Department of Nephrology, Papageorgiou General Hospital, Thessaloniki.

Eugenia Gkaliagkousi (E)

3rd Department of Internal Medicine, Papageorgiou General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.

Aikaterini Papagianni (A)

Department of Nephrology, Hippokration Hospital, Aristotle University of Thessaloniki.

Pantelis Sarafidis (P)

Department of Nephrology, Hippokration Hospital, Aristotle University of Thessaloniki.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH